Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
ASCO 2018
Pharma
Is Merck's I-O star really different? Depends who you ask
Many ASCO-watchers crowned Merck's Keytruda as king of the lung cancer market, but rivals Roche and BMS are kicking back.
Carly Helfand
Jun 6, 2018 9:08am
PARP pioneer AZ scores with Lynparza in prostate cancer
Jun 5, 2018 11:39am
ASCO Soundbites, 2018 edition
Jun 4, 2018 11:35am
New drugs, big spending: Cancer DTC spend surges to $500M
Jun 4, 2018 10:24am
BMS racks up Opdivo combo data to sell its new biomarker
Jun 4, 2018 6:59am
Merck's new partners hone plans for marketing onslaught
Jun 4, 2018 2:29am
